Ovarian Cancer Trial, Recruiting (NCT07491081)

Ovarian Cancer Trial, Recruiting NCT07491081 Sponsor: Queensland Centre for Gynaecological Cancer Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07491081 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 50 and 74 years old (inclusive).
You have gone through menopause naturally or had a hysterectomy, and have had no periods for at least 12 months in a row — OR you have been on hormone replacement therapy (HRT) for menopausal symptoms for at least 12 months.
You are willing and able to give written consent to take part.

Who may not be able to join:

You have previously been diagnosed with ovarian cancer.
You have had both of your ovaries surgically removed.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +61 7 3346 5073

Australian sites

Mater Misericordiae Ltd, Brisbane, Queensland

The University of Queensland, Brisbane, Queensland
+61 7 3346 5073

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07491081

Sponsor: Queensland Centre for Gynaecological Cancer

Phase: Not Applicable

Status: Recruiting

Condition: Ovarian Cancer

Trial contact: +61 7 3346 5073

More information: https://clinicaltrials.gov/study/NCT07491081

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 50 and 74 years old (inclusive).
You have gone through menopause naturally or had a hysterectomy, and have had no periods for at least 12 months in a row — OR you have been on hormone replacement therapy (HRT) for menopausal symptoms for at least 12 months.
You are willing and able to give written consent to take part.

Who may not be able to join:

You have previously been diagnosed with ovarian cancer.
You have had both of your ovaries surgically removed.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Queensland Centre for Gynaecological Cancer

Registry

ClinicalTrials.gov

Start date

1 February 2026

Est. completion

31 December 2028

Where this trial is recruiting

🇦🇺 Australia

2 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Proportion of participants with successful blood collection and extracellular vesicle extraction according to the study protocol (feasibility).; Proportion of eligible participants who provide informed consent to participate in the study among all individuals approached and assessed for eligibility (acceptability).; Effect of real-world sampling and processing methods on extracellular vesicle particle concentration (particles/mL) measured by nanoparticle tracking analysis (NTA) (quality).; Effect of real-world sampling and processing methods on EV size distribution (mean and mode, nm) measured...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov